Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations.
Pengfei Li, Annemarie C de Vries, Nassim Kamar, Maikel P Peppelenbosch, Qiuwei Pan
Author Information
- Pengfei Li: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, NL-3015 Rotterdam, Netherlands.
- Annemarie C de Vries: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, NL-3015 Rotterdam, Netherlands.
- Nassim Kamar: Department of Nephrology, Dialysis and Organ Transplantation, Centre Hospitalier Universitaire Rangueil, INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease, Paul Sabatier University, Toulouse, France.
- Maikel P Peppelenbosch: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, NL-3015 Rotterdam, Netherlands.
- Qiuwei Pan: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, NL-3015 Rotterdam, Netherlands. Electronic address: q.pan@erasmusmc.nl.
No abstract text available.
- Nature. 2021 Dec 21;:
[PMID: 34937889]
- Cell Host Microbe. 2022 Feb 9;30(2):154-162.e5
[PMID: 35120605]
- Cell Res. 2022 Mar;32(3):322-324
[PMID: 35058606]
- N Engl J Med. 2021 Aug 12;385(7):661-662
[PMID: 34161700]
- Clin Microbiol Infect. 2017 Apr;23(4):265.e9-265.e13
[PMID: 28003123]
- BMC Infect Dis. 2021 Aug 3;21(1):743
[PMID: 34344321]
- Lancet. 2021 Dec 11;398(10317):2126-2128
[PMID: 34871545]
- JAMA. 2021 May 25;325(20):2033-2035
[PMID: 33950236]
- Lancet Infect Dis. 2021 Oct;21(10):1345-1347
[PMID: 34411531]
- J Infect Dis. 2017 Dec 19;216(12):1513-1524
[PMID: 29029115]
- N Engl J Med. 2020 Dec 3;383(23):2291-2293
[PMID: 33176080]
Antibodies, Viral
COVID-19
Humans
Immunocompromised Host
SARS-CoV-2
